New considerations for colorectal cancer screening based on the demographic profile of colorectal cancer in a Greek population.

Greek cohort colonoscopy colorectal cancer public health screening

Journal

Molecular and clinical oncology
ISSN: 2049-9469
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 30 08 2021
accepted: 12 11 2021
entrez: 3 2 2022
pubmed: 4 2 2022
medline: 4 2 2022
Statut: ppublish

Résumé

Colorectal cancer screening has long been recommended for middle age and older individuals. Recent evidence indicates increasing incidence and mortality among young adults. Therefore, the present study re-examined the current recommendations using an asymptomatic average-risk population screened by colonoscopy. A total of 716 participants of a wide age range were prospectively enrolled in an open-access endoscopic screening program based on self-referral. Comparisons between different age, gender and location groups, and receiver operating characteristic curves (ROC) curves for best age selection for detection of lesions were employed. Increased incidence of advanced lesions was observed in adults <50 years old. Although the polyp size was <1 cm in 85% of the cohort, a significant number of participants harbored advanced lesions. A disturbing incidence of lesions in women 30-49 years was located mainly in the left colon. One-third of the important pathology resides exclusively in the right colon. ROC curves demonstrated that with the current starting age of screening at 50 years, 92% of polyps and 95% of adenomas could be detected by colonoscopy, but a number of potential precancerous lesions will appear at an earlier age and therefore will be missed. The present study supported the notion that it is critical to reduce screening initiation below the currently accepted age of 50 years. Colonoscopy is a suitable method for addressing the increased prevalence of proximal lesions and the meticulous resection of smaller polyps.

Identifiants

pubmed: 35111323
doi: 10.3892/mco.2022.2490
pii: MCO-16-3-02490
pmc: PMC8771310
doi:

Types de publication

Journal Article

Langues

eng

Pagination

57

Informations de copyright

Copyright: © Panteris et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

JAMA. 2016 Jun 21;315(23):2595-609
pubmed: 27305518
J Adolesc Young Adult Oncol. 2014 Dec 1;3(4):176-184
pubmed: 25538862
Cancer Med. 2018 Aug;7(8):4077-4086
pubmed: 29932308
Eur J Gastroenterol Hepatol. 2009 Jun;21(6):650-5
pubmed: 19445041
Clin Gastroenterol Hepatol. 2006 Mar;4(3):343-8
pubmed: 16527698
Gastroenterology. 2008 May;134(5):1311-5
pubmed: 18471508
Cancer. 2006 Sep 1;107(5 Suppl):1153-61
pubmed: 16862554
Gastrointest Endosc. 2012 May;75(5):1022-30
pubmed: 22405698
Gastrointest Endosc. 2017 Jun;85(6):1169-1176.e1
pubmed: 28024986
Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):499-507
pubmed: 24443404
Gut. 2013 Jun;62(6):863-70
pubmed: 22525884
Gut. 2007 Nov;56(11):1585-9
pubmed: 17591622
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376186
Am J Gastroenterol. 2005 Mar;100(3):515-23; discussion 514
pubmed: 15743345
Am J Gastroenterol. 2006 Feb;101(2):255-62
pubmed: 16454827
Dig Dis Sci. 2020 Jun;65(6):1838-1849
pubmed: 31701261
Lancet Oncol. 2013 Jul;14(8):711-20
pubmed: 23746988
Cancer. 2014 May 1;120(9):1290-314
pubmed: 24343171
World J Gastroenterol. 2017 May 28;23(20):3632-3642
pubmed: 28611516
CA Cancer J Clin. 2018 Jul;68(4):250-281
pubmed: 29846947
BMC Gastroenterol. 2011 Sep 24;11:101
pubmed: 21943383
Front Public Health. 2017 Jul 24;5:179
pubmed: 28791283
Scand J Gastroenterol. 2020 Nov;55(11):1389
pubmed: 33045171
Cancer. 2020 May 15;126(10):2225-2249
pubmed: 32162336
Cancer Epidemiol. 2020 Jun;66:101704
pubmed: 32234586
Prev Med. 2014 May;62:132-41
pubmed: 24530610
World J Gastroenterol. 2018 Apr 14;24(14):1579-1582
pubmed: 29662295
World J Gastroenterol. 2018 Jan 7;24(1):124-138
pubmed: 29358889
Gastrointest Endosc. 2010 Sep;72(3):480-9
pubmed: 20638061
Cancer Res. 2010 Jul 1;70(13):5419-29
pubmed: 20530677
J Natl Cancer Inst. 2017 Sep 1;109(9):
pubmed: 28376154
Endoscopy. 2009 Jun;41(6):516-21
pubmed: 19533557
World J Gastroenterol. 2016 Aug 28;22(32):7365-72
pubmed: 27621582
Eur J Cancer Prev. 2015 Sep;24(5):386-90
pubmed: 25380192
J Med Screen. 2013;20(3):125-48
pubmed: 24197771
Gut. 2019 Oct;68(10):1820-1826
pubmed: 31097539
Gastroenterology. 2017 Jul;153(1):307-323
pubmed: 28600072
Expert Rev Mol Diagn. 2011 Jul;11(6):605-16
pubmed: 21745014
J Investig Med. 2017 Feb;65(2):311-315
pubmed: 27864324
Aliment Pharmacol Ther. 2010 Jan 15;31(2):210-7
pubmed: 19814745
PLoS One. 2019 Dec 5;14(12):e0225547
pubmed: 31805076

Auteurs

Vasileios Panteris (V)

Gastroenterology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.

Panagiotis Karantanos (P)

Gastroenterology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.

Nikolaos Vasilakis (N)

Gastroenterology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.

Stephanie Vgenopoulou (S)

Histopathology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.

Georgia Lymperopoulou (G)

Gastroenterology Department, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.

Georgios Feretzakis (G)

Department of Quality Control, Research and Continuing Education, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.

Ilias Dalainas (I)

General Manager, Sismanogleio-Amalia Fleming General Hospital, 15126 Athens, Greece.

Elias Kouroumalis (E)

University of Crete Medical School, 71500 Heraklion, Greece.

Classifications MeSH